|
Market Closed -
Bombay S.E.
06:02:26 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 177.75 INR | -3.84% |
|
+8.78% | +116.11% |
Company Valuation: IOL Chemicals and Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16,608 | 21,222 | 17,964 | 21,354 | 52,175 | - |
| Change | - | 27.78% | -15.35% | 18.87% | 144.33% | - |
| Enterprise Value (EV) | 16,608 | 21,222 | 17,964 | 21,354 | 52,175 | 52,175 |
| Change | - | 27.78% | -15.35% | 18.87% | 144.33% | 0% |
| P/E | 11.9x | 15.8x | 17.8x | 15.5x | 23.7x | 17.1x |
| PBR | 1.1x | 1.32x | 1.06x | 1.19x | 2.66x | 2.4x |
| PEG | - | -4.68x | -0.7x | 0.4x | 0.4x | 0.4x |
| Capitalization / Revenue | 0.75x | 1x | 0.86x | 0.92x | 1.9x | 1.61x |
| EV / Revenue | 0x | 0x | 0x | 0x | 1.9x | 1.61x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 14.3x | - |
| EV / EBIT | 0x | 0x | 0x | 0x | 16.7x | - |
| EV / FCF | -0x | 0x | -0x | 0x | 18.8x | 28.7x |
| FCF Yield | -5.39% | 0.78% | -1.94% | 1.94% | 5.32% | 3.48% |
| Dividend per Share 2 | 0.8 | 1 | 4 | - | - | - |
| Rate of return | 1.41% | 1.38% | 6.54% | - | - | - |
| EPS 2 | 4.74 | 4.58 | 3.44 | 4.69 | 7.5 | 10.4 |
| Distribution rate | 16.9% | 21.8% | 116% | - | - | - |
| Net sales 1 | 22,171 | 21,328 | 20,792 | 23,191 | 27,424 | 32,403 |
| EBITDA 1 | 2,257 | 2,306 | 2,023 | 2,690 | 3,647 | - |
| EBIT 1 | 2,051 | 1,677 | 1,303 | 1,887 | 3,123 | - |
| Net income 1 | 1,391 | 1,344 | 1,011 | 1,376 | 2,198 | - |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 56.58 | 72.30 | 61.20 | 72.75 | 177.75 | 177.75 |
| Nbr of stocks (in thousands) | 293,528 | 293,528 | 293,528 | 293,528 | 293,528 | - |
| Announcement Date | 4/28/23 | 5/14/24 | 5/16/25 | 5/20/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 23.7x | - | - | - | 549M | ||
| 41.54x | 14.06x | 31.11x | 0.48% | 1,263B | ||
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | ||
| 38.61x | 8.62x | 17.83x | 2.33% | 521B | ||
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | ||
| 109.15x | 6.06x | 25.73x | 2.28% | 369B | ||
| 23.19x | 5.97x | 14.41x | 2.71% | 307B | ||
| 24.47x | 4.9x | 13.63x | 1.77% | 290B | ||
| 29.56x | 7.53x | 13.48x | 2.16% | 252B | ||
| -49.1x | 7.47x | 29.35x | 1.93% | 212B | ||
| Average | 30.29x | 7.40x | 19.73x | 2.01% | 426.25B | |
| Weighted average by Cap. | 37.28x | 8.84x | 21.96x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IOLCP Stock
- Valuation IOL Chemicals and Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















